Back to Search
Start Over
Valneva licenses Shigella vaccine candidate from LimmaTech
- Source :
- M2 EquityBites (EQB). August 1, 2024
- Publication Year :
- 2024
-
Abstract
- M2 EQUITYBITES-August 1, 2024-Valneva licenses Shigella vaccine candidate from LimmaTech (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Vaccine companies Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and LimmaTech Biologics AG announced on Thursday a strategic [...]
- Subjects :
- Valneva SE -- Licensing agreements
Euronext Paris S.A. -- Licensing agreements
Biological products industry -- Licensing agreements
Biotechnology industry -- Licensing agreements
Vaccines -- Licensing agreements
Securities industry -- Licensing agreements
Securities industry
Company licensing agreement
Business
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 EquityBites (EQB)
- Publication Type :
- News
- Accession number :
- edsgcl.803381139